Search results
Appearance
The page ""Actelion Receives Swissmedic Approval for Uptravi (Selexipag) for Treatment of Pulmonary Arterial Hypertension" journal" does not exist. You can create a draft and submit it for review or request that a redirect be created, but consider checking the search result below to see whether the topic is already covered.
- "Thomson Reuters ONE". Actelion Receives Swissmedic Approval for Uptravi (Selexipag) for Treatment of Pulmonary Arterial Hypertension. COMTEX News Network...25 KB (2,589 words) - 03:31, 21 May 2024